Matching slides 33,236
Current window 12,961-12,990
Pages 1,108
Rows per page 30
Arc: Monroes Sequenceclear collectionreset all

Arc

12,961-12,990 of 33,236

filter-aware
20
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
21
Includes leadership headshots and disclaimer.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
22
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
23
The slide uses two bar charts to demonstrate financial performance and operating leverage.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
24
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
25
Includes company overview and product logos on the right side.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
26
The slide uses a process flow diagram to show how operational improvements (EBITDA growth, working capital, deleveraging) feed into specific divestiture and IPO events.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
27
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
28
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
29
Bausch Health Companies | Results Presentation Deck | 90 slidesBausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
30
The slide uses a flow diagram to show how business lines were re-categorized into new segments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
31
The slide details the financial impact of segment restructuring, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses specific financial growth targets to communicate future performance expectations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
Slide 32 of a Bausch Health presentation.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a timeline framework to map four distinct drug development programs against a 2019-2027 calendar.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The table tracks financial performance changes for products that have experienced or are anticipating LOE.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units due to patent expirations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
The table tracks financial impact of patent expirations across Bausch & Lomb, Int'l Rx, Salix, Ortho Dermatologics, and Diversified Products.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
The table compares inventory levels between Q1 and Q2 for two consecutive years.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks inventory efficiency across different business segments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
The slide includes a specific callout for organic revenue growth and a disclaimer regarding corporate cost allocation.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
The slide includes a specific callout for +28% organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics like Constant Currency and Organic Change.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The table includes reported, constant currency, and organic change metrics.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
Includes detailed footnotes regarding non-GAAP adjustments and currency impacts.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
Includes footnotes regarding non-GAAP metrics and segment reporting.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The slide highlights a 12% organic growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide highlights a 10% organic revenue growth for the International Rx segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The slide includes a specific callout for Global Solta's organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit